| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |